TY - JOUR
T1 - Is It True What They Say about Interferon?
AU - Weimar, W.
AU - Schellekens, H.
AU - Merigan, Thomas C.
PY - 1979/4/19
Y1 - 1979/4/19
N2 - To the Editor: Two enthusiastic editorials on exogenous interferon therapy have appeared in the Journal within seven months.1,2 This might easily give the impression that a breakthrough for interferon as a therapeutic agent is at hand. True, it has clearly been shown that interferon is effective in herpes zoster, provided that high-dose therapy is started early in the course of the disease.3 Equally true, topical application of interferon in herpes keratitis can be of clinical value if combined with debridement or minimal wiping.4,5 However, in other fields, unequivocal evidence for the usefulness of interferon has not been provided yet. The.
AB - To the Editor: Two enthusiastic editorials on exogenous interferon therapy have appeared in the Journal within seven months.1,2 This might easily give the impression that a breakthrough for interferon as a therapeutic agent is at hand. True, it has clearly been shown that interferon is effective in herpes zoster, provided that high-dose therapy is started early in the course of the disease.3 Equally true, topical application of interferon in herpes keratitis can be of clinical value if combined with debridement or minimal wiping.4,5 However, in other fields, unequivocal evidence for the usefulness of interferon has not been provided yet. The.
UR - http://www.scopus.com/inward/record.url?scp=0018795554&partnerID=8YFLogxK
U2 - 10.1056/NEJM197904193001614
DO - 10.1056/NEJM197904193001614
M3 - Letter
C2 - 423945
AN - SCOPUS:0018795554
SN - 0028-4793
VL - 300
SP - 923
EP - 924
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 16
ER -